Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-04-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2016.02.038PMID 26924357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation

  2016cited by this paper
• Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery.

  2015cited by this paper
• Preparation and performance evaluation of emulsomes as a drug delivery system for silybin

  2015cited by this paper
• Emulsomes Meet S-layer Proteins: An Emerging Targeted Drug Delivery System

  2015cited by this paper
• Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters.

  2015cited by this paper
• Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting.

  2014influential reference
• Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals

  2014cited by this paper
• Preparation of Tween 80-Zn/Al-Levodopa-Layered Double Hydroxides Nanocomposite for Drug Delivery System

  2014cited by this paper
• Effect of Cytokines on Osteoclast Formation and Bone Resorption during Mechanical Force Loading of the Periodontal Membrane

  2014cited by this paper
• Design and development of Candesartan cilexetil emulsomal drug delivery systems for the effective management of cardiovascular diseases

  2014influential reference
• Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats.

  2014influential reference
• Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy

  2014cited by this paper
• Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.

  2014influential reference
• Development of carbamazepine transnasal microemulsion for treatment of epilepsy

  2013cited by this paper
• Composition, structure and properties of POPC-triolein mixtures. Evidence of triglyceride domains in phospholipid bilayers.

  2013cited by this paper
• In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration.

  2013cited by this paper
• Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.

  2013cited by this paper
• Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin

  2013influential reference
• Emulsomes: a novel liposomal formulation for sustained drug delivery

  2013cited by this paper
• S-layer coated emulsomes as potential nanocarriers.

  2013influential reference
• Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route.

  2012cited by this paper
• Drug Transport across the Blood–Brain Barrier

  2012cited by this paper
• Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.

  2012cited by this paper
• Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.

  2012cited by this paper
• RETRACTED ARTICLE Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis

  2012influential reference
• Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis.

  2012cited by this paper
• Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers.

  2012influential reference
• Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.

  2011cited by this paper
• Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

  2011cited by this paper
• Methotrexate-Loaded Chitosan- and Glycolchitosan-Based Nanoparticles: A Promising Strategy for the Administration of the Anticancer Drug to Brain Tumors

  2011cited by this paper
• Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism

  2011cited by this paper
• Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment

  2011cited by this paper
• Intranasal clobazam delivery in the treatment of status epilepticus.

  2011influential reference
• Soybean-based Surfactants and Their Applications

  2011cited by this paper
• Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.

  2011cited by this paper
• Oxcarbazepine: validation and application of an analytical method

  2010cited by this paper
• Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.

  2010cited by this paper
• Getting into the Brain

  2009cited by this paper
• Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.

  2009influential reference
• Retinal ganglion cell toxicity due to oxcarbazepine and valproic acid treatment in rat.

  2009influential reference
• Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.

  2009cited by this paper
• Adverse Effects of Antiepileptic Drugs

  2008cited by this paper
• Toxicity of CdSe Nanoparticles in Caco-2 Cell Cultures

  2008cited by this paper
• Potential of solid lipid nanoparticles in brain targeting.

  2008cited by this paper
• Oxcarbazepine improves mood in patients with epilepsy.

  2007cited by this paper
• Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan

  2006cited by this paper
• Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery

  2006cited by this paper
• Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

  2006cited by this paper
• Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.

  2006influential reference
• Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.

  2006cited by this paper
• Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.

  2006influential reference
• Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.

  2005cited by this paper
• Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.

  2005cited by this paper
• Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.

  2004cited by this paper
• Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.

  2004cited by this paper
• Coenzyme q10 in patients with end‐stage heart failure awaiting cardiac transplantation: A randomized, placebo‐controlled study

  2004cited by this paper
• Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.

  2004cited by this paper
• Solid lipid nanoparticles for parenteral drug delivery.

  2004cited by this paper
• Coenzyme Q10 in patients with end‐stage heart failure awaiting cardiac transplantation: A randomized, placebo‐controlled study

  2004cited by this paper
• Quantitation of oxcarbazepine and its metabolites in human plasma by micellar electrokinetic chromatography.

  2003cited by this paper
• An In Vitro Study of New Antiepileptic Drugs and Astrocytes

  2003cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.

  2002influential reference
• Oxcarbazepine

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Liposomal bleomycin: increased therapeutic activity and decreased pulmonary toxicity in mice.

  2001cited by this paper
• Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy

  2000cited by this paper
• Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat.

  1999cited by this paper
• Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta

  1998cited by this paper
• Drug transport across the blood-brain barrier

  1992cited by this paper
• Surfaces, Interfaces, and Colloids: Principles and Applications

  1991cited by this paper
• International Journal of Nanomedicine Dovepress Enhanced Brain Targeting of Temozolomide in Polysorbate-80 Coated Polybutylcyanoacrylate Nanoparticles

  year unknowncited by this paper

• PEG-decorated emulsomal gel loaded levocetirizine dihydrochloride as repurposed cure for effective management of methicillin-resistant Staphylococcus aureus (MRSA) vaginal infection: D-optimal design optimization, ex-vivo, in-silico, and in-vivo studies

  2026cites this paper
• Visualizing the spatial distribution of Alprazolam in the mouse brain following nasal administration using desorption electrospray ionization mass spectrometry imaging.

  2025cites this paper
• GREEN SYNTHESIS OF SPIRULINA OIL-BASED NANOVESICLES AS A BIOENHANCER FOR THE INTRANASAL BRAIN TARGETING OF STATINS: CELL LINE STUDY ON HUMAN BRAIN CANCER CELL SNB-75 AND PHARMACOKINETICS ON RATS

  2025cites this paper
• " TPGS-Functionalized Nanocarriers with improved flavonoid oral bioavailability and therapeutic Action: Pharmacokinetic and Mechanistic Insights in Diabetes-Induced Retinopathy ".

  2025cites this paper
• Surface-engineered chitosan-coated nanostructured lipid carriers for intranasal delivery of Oxcarbazepine and Vitamin E oil in epilepsy management

  2025cites this paper
• A triple strategy employing the revisited diosmin, nano emulsomes gel, and the topical route for psoriasis management in a UV-induced model

  2025cites this paper
• Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery

  2025cites this paper
• Intranasal administration of antiseizure drugs using new formulation trends: one step closer to reach clinical trials

  2025influential citation
• Emulsomal Nanovesicles: A Platform for Boosting the Oral Bioavailability and Selective Cytotoxicity of Tamoxifen Citrate Towards Breast Cancer Cells

  2025cites this paper
• The Role of Glycolipids and their Toxicity in the Context of Nanomaterials and Nanoparticles: A Review of the Literature.

  2025cites this paper
• Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery

  2024cites this paper
• Rhamnosomes: A new generation of flexible vesicles for a boosted targeted nose-to-brain delivery of selegiline in the treatment of Parkinson's disease

  2024cites this paper
• Dihydroquercetin nanoparticles nasal gel is a promising formulation for amelioration of Alzheimer's disease.

  2024cites this paper
• Recent progress in nanoparticulate-based intranasal delivery for treating of different central nervous system diseases

  2024cites this paper
• Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature

  2024cites this paper
• Review on novel targeted enzyme drug delivery systems: enzymosomes.

  2024cites this paper
• Nanotechnological advances in the treatment of epilepsy: a comprehensive review

  2024cites this paper
• Coating with tripolyphosphate-crosslinked chitosan as a novel approach for enhanced stability of emulsomes following oral administration: Rutin as a model drug with improved anti-hyperlipidemic effect in rats.

  2023cites this paper
• Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities

  2023cites this paper
• Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats

  2023cites this paper
• A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases

  2023cites this paper
• Nano‐delivery systems as a promising therapeutic potential for epilepsy: Current status and future perspectives

  2023cites this paper
• Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration

  2023cites this paper
• Phytomedicinal flavonoid loaded phospholipid sheathed lipidic nano-carriers as a platform with boosted oral anti-mycobacterium activity

  2023cites this paper
• Preparation of a novel brain-targeted EGCG liposome and its antioxidative neuroprotection

  2023cites this paper
• Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

  2023cites this paper
• Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport

  2023cites this paper
• Atorvastatin-loaded emulsomes foam as a topical antifungal formulation

  2022cites this paper
• The skin delivery of Tofacitinib citrate using transethosomes and hybridized ethosomes/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays.

  2022cites this paper
• Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation.

  2022cites this paper
• Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

  2022cites this paper
• A Brain-Targeted Approach to Ameliorate Memory Disorders in a Sporadic Alzheimer’s Disease Mouse Model via Intranasal Luteolin-Loaded Nanobilosomes

  2022cites this paper
• Synthesis of rod-like CeO2 nanoparticles and their application to catalyze the luminal–O2 chemiluminescence reaction used in the determination of oxcarbazepine and ascorbic acid

  2022cites this paper
• Inclusion of a Phytomedicinal Flavonoid in Biocompatible Surface-Modified Chylomicron Mimic Nanovesicles with Improved Oral Bioavailability and Virucidal Activity: Molecular Modeling and Pharmacodynamic Studies

  2022influential citation
• Novel Luteolin-Loaded Chitosan Decorated Nanoparticles for Brain-Targeting Delivery in a Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways

  2022cites this paper
• Boosting the anti-inflammatory effect of self-assembled hybrid lecithin–chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and in vivo modeling

  2022influential citation
• Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties

  2022cites this paper
• Design and synthesis of new trimethoxylphenyl-linked combretastatin analogues loaded on diamond nanoparticles as a panel for ameliorated solubility and antiproliferative activity

  2022cites this paper
• Phyto-emulsomes as a novel nano-carrier for morine hydrate to combat leukemia: In vitro and pharmacokinetic study

  2022cites this paper
• Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment

  2022influential citation
• Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.

  2022cites this paper
• Optimized Apamin-Mediated Nano-Lipidic Carrier Potentially Enhances the Cytotoxicity of Ellagic Acid against Human Breast Cancer Cells

  2022cites this paper
• Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments

  2022influential citation
• Repurposing of atorvastatin emulsomes as a topical antifungal agent

  2022cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity

  2021cites this paper
• Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices

  2021cites this paper
• RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment

  2021influential citation
• Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.

  2021cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• Vesicular carriers for direct nose-to-brain drug delivery

  2021cites this paper
• Particulate carriers for nose-to-brain delivery

  2021cites this paper
• NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER

  2021cites this paper
• Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases

  2021cites this paper
• Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

  2021cites this paper
• Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery

  2020cites this paper
• Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.

  2020cites this paper
• A critical review of synthesis procedures, applications and future potential of nanoemulsions.

  2020cites this paper
• Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy.

  2020cites this paper
• Nasal Nanoemulsion: A Novel Approach for Targeting to Brain

  2020cites this paper
• “ DIRECT NOSE TO BRAIN DELIVERY OF NEUROTHERAPEUTICS-LOADED NANOEMULSION ”

  2019cites this paper
• Assessment of the toxicity of lipid nanocapsules and polymer nanoparticles on a neuronal cell model as a first step towards their development for nose-to-brain drug delivery

  2019cites this paper
• Active targeting towards and inside the brain based on nanoparticles: A Review.

  2019cites this paper
• Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel

  2019cites this paper
• Transmucosal Absorption Enhancers in the Drug Delivery Field

  2019cites this paper
• Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview

  2019cites this paper
• Nanoemulsions for “Nose-to-Brain” Drug Delivery

  2019cites this paper
• Drug targeting strategies into the brain for treating neurological diseases.

  2019cites this paper
• An update on the role of nanovehicles in nose-to-brain drug delivery.

  2018cites this paper
• Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents

  2018cites this paper
• A Tailored Thermosensitive PLGA-PEG-PLGA/Emulsomes Composite for Enhanced Oxcarbazepine Brain Delivery via the Nasal Route

  2018influential citation
• An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems

  2018cites this paper
• Lipid based nanocarriers: a translational perspective.

  2018cites this paper
• Nanosystems in nose‐to‐brain drug delivery: A review of non‐clinical brain targeting studies

  2018cites this paper
• Progress in brain targeting drug delivery system by nasal route

  2017cites this paper